CN102676650B - Cpt1a基因或蛋白的定量检测在食管鳞癌预后判断中的应用 - Google Patents
Cpt1a基因或蛋白的定量检测在食管鳞癌预后判断中的应用 Download PDFInfo
- Publication number
- CN102676650B CN102676650B CN201210058744.XA CN201210058744A CN102676650B CN 102676650 B CN102676650 B CN 102676650B CN 201210058744 A CN201210058744 A CN 201210058744A CN 102676650 B CN102676650 B CN 102676650B
- Authority
- CN
- China
- Prior art keywords
- cpt1a
- cell carcinoma
- squamous cell
- esophageal squamous
- quantitative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010061534 Oesophageal squamous cell carcinoma Diseases 0.000 title claims abstract description 60
- 208000036765 Squamous cell carcinoma of the esophagus Diseases 0.000 title claims abstract description 59
- 208000007276 esophageal squamous cell carcinoma Diseases 0.000 title claims abstract description 59
- 101150073133 Cpt1a gene Proteins 0.000 title claims abstract description 53
- 238000001514 detection method Methods 0.000 title claims abstract description 35
- 238000003745 diagnosis Methods 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 50
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 17
- 238000012360 testing method Methods 0.000 claims abstract description 16
- 230000002018 overexpression Effects 0.000 claims abstract description 10
- 102100027943 Carnitine O-palmitoyltransferase 1, liver isoform Human genes 0.000 claims description 29
- 101000859570 Homo sapiens Carnitine O-palmitoyltransferase 1, liver isoform Proteins 0.000 claims description 29
- 108091034117 Oligonucleotide Proteins 0.000 claims description 14
- 239000012634 fragment Substances 0.000 claims description 14
- 238000012151 immunohistochemical method Methods 0.000 claims description 13
- 239000000523 sample Substances 0.000 claims description 13
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 claims description 11
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 claims description 11
- 238000013016 damping Methods 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 abstract description 27
- 102000004169 proteins and genes Human genes 0.000 abstract description 21
- 230000014509 gene expression Effects 0.000 abstract description 17
- 238000004393 prognosis Methods 0.000 abstract description 16
- 230000004083 survival effect Effects 0.000 abstract description 16
- 210000004027 cell Anatomy 0.000 description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 16
- 210000001519 tissue Anatomy 0.000 description 16
- 206010028980 Neoplasm Diseases 0.000 description 14
- 108020004414 DNA Proteins 0.000 description 11
- 238000005259 measurement Methods 0.000 description 10
- 238000003753 real-time PCR Methods 0.000 description 10
- 238000005406 washing Methods 0.000 description 9
- 238000011529 RT qPCR Methods 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 230000003321 amplification Effects 0.000 description 6
- 230000004087 circulation Effects 0.000 description 6
- 238000003199 nucleic acid amplification method Methods 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- 238000010818 SYBR green PCR Master Mix Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 208000007433 Lymphatic Metastasis Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 210000004881 tumor cell Anatomy 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- 101150112014 Gapdh gene Proteins 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 238000013115 immunohistochemical detection Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000007477 logistic regression Methods 0.000 description 3
- 238000000386 microscopy Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 101000909313 Homo sapiens Carnitine O-palmitoyltransferase 2, mitochondrial Proteins 0.000 description 2
- 101000989606 Homo sapiens Cholinephosphotransferase 1 Proteins 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000022766 lymph node neoplasm Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000001921 nucleic acid quantification Methods 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 238000010837 poor prognosis Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
- 108091012583 BCL2 Proteins 0.000 description 1
- 101100008048 Caenorhabditis elegans cut-4 gene Proteins 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 108010018424 Carnitine O-palmitoyltransferase Proteins 0.000 description 1
- 102000002666 Carnitine O-palmitoyltransferase Human genes 0.000 description 1
- 102100027947 Carnitine O-palmitoyltransferase 1, muscle isoform Human genes 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 101000859574 Homo sapiens Carnitine O-palmitoyltransferase 1, muscle isoform Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012916 chromogenic reagent Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000012308 immunohistochemistry method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000004876 tela submucosa Anatomy 0.000 description 1
Abstract
Description
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210058744.XA CN102676650B (zh) | 2011-03-09 | 2012-03-08 | Cpt1a基因或蛋白的定量检测在食管鳞癌预后判断中的应用 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110054980.X | 2011-03-09 | ||
CN201110054980 | 2011-03-09 | ||
CN201110054980X | 2011-03-09 | ||
CN201210058744.XA CN102676650B (zh) | 2011-03-09 | 2012-03-08 | Cpt1a基因或蛋白的定量检测在食管鳞癌预后判断中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102676650A CN102676650A (zh) | 2012-09-19 |
CN102676650B true CN102676650B (zh) | 2015-08-05 |
Family
ID=46809200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210058744.XA Expired - Fee Related CN102676650B (zh) | 2011-03-09 | 2012-03-08 | Cpt1a基因或蛋白的定量检测在食管鳞癌预后判断中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102676650B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104894126B (zh) * | 2015-06-23 | 2016-02-17 | 济南市儿童医院 | 一种检测cpt-ⅱ基因突变的引物及试剂盒 |
CN104878120B (zh) * | 2015-06-26 | 2016-02-17 | 济南市儿童医院 | 一种检测cpt1b基因突变的引物及试剂盒 |
CN105112515A (zh) * | 2015-08-14 | 2015-12-02 | 深圳市众偱精准医学研究院 | Fbxw7基因及表达产物在肾癌检测、肾癌药物制备中的用途 |
CN105063215B (zh) * | 2015-08-19 | 2017-07-07 | 济南市儿童医院 | 用于检测cpt1a基因突变的引物及试剂盒 |
CN111128385B (zh) * | 2020-01-17 | 2020-11-10 | 河南科技大学第一附属医院 | 一种用于食管鳞癌的预后预警系统及其应用 |
CN113549702A (zh) * | 2021-09-14 | 2021-10-26 | 北京大学第三医院(北京大学第三临床医学院) | 一种人脂肪酸代谢关键酶基因检测方法以及试剂盒 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1556413A (zh) * | 2004-01-08 | 2004-12-22 | 中南大学湘雅医学院肿瘤研究所 | 一种用于肿瘤早期诊断的组织芯片及制备器具 |
CN1618985A (zh) * | 2003-11-21 | 2005-05-25 | 中国医学科学院肿瘤医院肿瘤研究所 | 一个新的食管癌标志基因rpl14及其用途 |
-
2012
- 2012-03-08 CN CN201210058744.XA patent/CN102676650B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1618985A (zh) * | 2003-11-21 | 2005-05-25 | 中国医学科学院肿瘤医院肿瘤研究所 | 一个新的食管癌标志基因rpl14及其用途 |
CN1556413A (zh) * | 2004-01-08 | 2004-12-22 | 中南大学湘雅医学院肿瘤研究所 | 一种用于肿瘤早期诊断的组织芯片及制备器具 |
Non-Patent Citations (3)
Title |
---|
BAC Clones Related to Prognosis in Patients with Esophageal Squamous Carcinoma: An Array Comparative Genomic Hybridization Study;Shigeo Hirasaki等;《The Oncologist》;20071231;第12卷;第407页右栏第2段至414页右栏第1段 * |
Genomic characterization of esophageal squamous cell carcinoma from a high-risk population in China;Nan Hu等;《Cancer Res.》;20090731;第69卷(第14期);5908–5917 * |
食管鳞癌基因组改变及预后相关基因的研究;史志周;《中国博士学位论文全文数据库 医药卫生科技辑》;20111115(第11期);E072-58,具体参见第46页至第50页第三部分 * |
Also Published As
Publication number | Publication date |
---|---|
CN102676650A (zh) | 2012-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102676650B (zh) | Cpt1a基因或蛋白的定量检测在食管鳞癌预后判断中的应用 | |
ES2652600T3 (es) | Diagnóstico y tratamiento de cáncer de mama | |
Molinié et al. | Alpha-methyl CoA racemase expression in renal cell carcinomas | |
ES2440747T3 (es) | Procedimientos de diagnóstico para determinar el pronóstico del cáncer de pulmón de células no pequeñas | |
PT1781814E (pt) | Métodos e kit para o prognóstico do cancro da mama | |
CN105473735A (zh) | 用于肿瘤分子亚型分型的方法和试剂盒 | |
Maltoni et al. | CTCs in early breast cancer: A path worth taking | |
CN104263815B (zh) | 一组用于激素受体阳性乳腺癌预后的基因及其应用 | |
CN104011227A (zh) | 用于前列腺癌的诊断、预后和评估治疗性/预防性治疗的材料和方法 | |
Behjati et al. | Prognostic value of chromosome 1 and 8 copy number in invasive ductal breast carcinoma among Iranian women: an interphase FISH analysis | |
CN106319062B (zh) | 一种用于甲状腺癌辅助诊断或疗效预测的微创试剂盒 | |
Ucer et al. | New candidates in the differential diagnosis of malignant mesothelioma from benign mesothelial hyperplasia and adenocarcinoma; DARS2 and suprabasin | |
CN105420393A (zh) | 检测brca1基因表达的引物、探针及试剂盒 | |
CN115449555B (zh) | Adgra2作为乳腺癌化疗疗效和预后评价生物标志物的应用 | |
CN116087520A (zh) | Gpt2作为乳腺癌预后评价生物标志物的应用 | |
CN109022585A (zh) | Pbld基因在制备肾透明细胞癌诊断和预测预后药物中的应用 | |
CN114778844A (zh) | Pld1作为评估肿瘤患者对于化疗药物敏感性的分子标志物的用途 | |
CN108588222B (zh) | 一种肝细胞癌辅助诊断或者疾病监测试剂盒及应用 | |
CN111948395A (zh) | 用于诊断三阴性乳腺癌免疫调节亚型的四联标志物及其应用 | |
CN103436621B (zh) | 一种快速检测CK19mRNA表达量的方法及其试剂盒 | |
Zhao et al. | Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling | |
Zhao et al. | Synchronous detection of miRNAs, their targets and downstream proteins in transferred FFPE sections: Applications in clinical and basic research | |
CN105177120A (zh) | 一种快速检测top2a基因异常的荧光原位杂交探针 | |
CN113755594B (zh) | 一种预测小细胞肺癌辅助化疗获益和识别化疗耐药治疗靶点的系统和应用 | |
CN109022575A (zh) | 一种可用于犬乳腺肿瘤诊断和预后判断的分子标志物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TUMOR HOSPITAL, CHINESE MEDICAL ACADEMY Free format text: FORMER OWNER: TUMOUR INST., CHINA MEDICAL SCIENCE RESEARCH ACADEMY Effective date: 20150811 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150811 Address after: 100021 Beijing, Panjiayuan, South Lane, No. 17, No. Patentee after: CANCER HOSPITAL, CHINESE ACEDEMY OF MEDICAL SCIENCES Address before: 100021 Beijing, Panjiayuan, South Lane, No. 17, No. Patentee before: CANCER INSTITUTE, CHINESE ACADEMY OF MEDICAL SCIENCES |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150805 |
|
CF01 | Termination of patent right due to non-payment of annual fee |